Annual Revenue
$153.73 M
+$85.96 M+126.84%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual revenue is $153.73 million, with the most recent change of +$85.96 million (+126.84%) on December 31, 2023.
- During the last 3 years, STRO annual revenue has risen by +$111.01 million (+259.84%).
- STRO annual revenue is now at all-time high.
Performance
STRO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$8.52 M
-$17.19 M-66.86%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly revenue is $8.52 million, with the most recent change of -$17.19 million (-66.86%) on September 30, 2024.
- Over the past year, STRO quarterly revenue has dropped by -$105.20 million (-92.51%).
- STRO quarterly revenue is now -92.51% below its all-time high of $113.72 million, reached on December 31, 2023.
Performance
STRO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$160.96 M
-$8.40 M-4.96%
September 30, 2024
Summary
- As of February 7, 2025, STRO TTM revenue is $160.96 million, with the most recent change of -$8.40 million (-4.96%) on September 30, 2024.
- Over the past year, STRO TTM revenue has increased by +$7.22 million (+4.70%).
- STRO TTM revenue is now -4.96% below its all-time high of $169.36 million, reached on June 30, 2024.
Performance
STRO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
STRO Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +126.8% | -92.5% | +4.7% |
| 3 y3 years | +259.8% | -92.5% | +4.7% |
| 5 y5 years | +300.1% | -92.5% | +4.7% |
STRO Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +148.4% | -92.5% | +44.5% | -5.0% | +230.9% |
| 5 y | 5-year | at high | +259.8% | -92.5% | +44.5% | -5.0% | +300.4% |
| alltime | all time | at high | +300.1% | -92.5% | +110.9% | -5.0% | +819.8% |
Sutro Biopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $8.52 M(-66.9%) | $160.96 M(-5.0%) |
| Jun 2024 | - | $25.71 M(+97.6%) | $169.36 M(+9.9%) |
| Mar 2024 | - | $13.01 M(-88.6%) | $154.06 M(+0.2%) |
| Dec 2023 | $153.73 M(+126.8%) | $113.72 M(+572.0%) | $153.73 M(+216.0%) |
| Sep 2023 | - | $16.92 M(+62.5%) | $48.64 M(-14.5%) |
| Jun 2023 | - | $10.41 M(-17.8%) | $56.87 M(-23.7%) |
| Mar 2023 | - | $12.67 M(+46.8%) | $74.55 M(+10.0%) |
| Dec 2022 | $67.77 M(+9.5%) | $8.63 M(-65.7%) | $67.77 M(-2.9%) |
| Sep 2022 | - | $25.15 M(-10.5%) | $69.79 M(+31.3%) |
| Jun 2022 | - | $28.10 M(+376.4%) | $53.16 M(+0.1%) |
| Mar 2022 | - | $5.90 M(-44.6%) | $53.12 M(-14.2%) |
| Dec 2021 | $61.88 M(+44.8%) | $10.65 M(+25.1%) | $61.88 M(+4.0%) |
| Sep 2021 | - | $8.52 M(-69.6%) | $59.50 M(-13.5%) |
| Jun 2021 | - | $28.05 M(+91.3%) | $68.81 M(+37.0%) |
| Mar 2021 | - | $14.66 M(+77.1%) | $50.23 M(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $42.72 M(-0.0%) | $8.28 M(-53.6%) | $42.72 M(-6.6%) |
| Sep 2020 | - | $17.82 M(+88.2%) | $45.75 M(+13.8%) |
| Jun 2020 | - | $9.47 M(+32.4%) | $40.20 M(-2.6%) |
| Mar 2020 | - | $7.15 M(-36.7%) | $41.26 M(-3.5%) |
| Dec 2019 | $42.74 M(+11.2%) | $11.30 M(-7.9%) | $42.74 M(-15.4%) |
| Sep 2019 | - | $12.28 M(+16.6%) | $50.52 M(+9.6%) |
| Jun 2019 | - | $10.53 M(+22.0%) | $46.08 M(+11.7%) |
| Mar 2019 | - | $8.63 M(-54.8%) | $41.26 M(+7.4%) |
| Dec 2018 | $38.42 M(-25.7%) | $19.09 M(+143.6%) | $38.42 M(+64.4%) |
| Sep 2018 | - | $7.84 M(+37.4%) | $23.37 M(-29.2%) |
| Jun 2018 | - | $5.70 M(-1.5%) | $33.04 M(+20.9%) |
| Mar 2018 | - | $5.79 M(+43.4%) | $27.33 M(+26.9%) |
| Dec 2017 | $51.74 M(-13.4%) | $4.04 M(-76.9%) | $21.54 M(+23.1%) |
| Sep 2017 | - | $17.50 M | $17.50 M |
| Dec 2016 | $59.73 M | - | - |
FAQ
- What is Sutro Biopharma annual revenue?
- What is the all time high annual revenue for Sutro Biopharma?
- What is Sutro Biopharma annual revenue year-on-year change?
- What is Sutro Biopharma quarterly revenue?
- What is the all time high quarterly revenue for Sutro Biopharma?
- What is Sutro Biopharma quarterly revenue year-on-year change?
- What is Sutro Biopharma TTM revenue?
- What is the all time high TTM revenue for Sutro Biopharma?
- What is Sutro Biopharma TTM revenue year-on-year change?
What is Sutro Biopharma annual revenue?
The current annual revenue of STRO is $153.73 M
What is the all time high annual revenue for Sutro Biopharma?
Sutro Biopharma all-time high annual revenue is $153.73 M
What is Sutro Biopharma annual revenue year-on-year change?
Over the past year, STRO annual revenue has changed by +$85.96 M (+126.84%)
What is Sutro Biopharma quarterly revenue?
The current quarterly revenue of STRO is $8.52 M
What is the all time high quarterly revenue for Sutro Biopharma?
Sutro Biopharma all-time high quarterly revenue is $113.72 M
What is Sutro Biopharma quarterly revenue year-on-year change?
Over the past year, STRO quarterly revenue has changed by -$105.20 M (-92.51%)
What is Sutro Biopharma TTM revenue?
The current TTM revenue of STRO is $160.96 M
What is the all time high TTM revenue for Sutro Biopharma?
Sutro Biopharma all-time high TTM revenue is $169.36 M
What is Sutro Biopharma TTM revenue year-on-year change?
Over the past year, STRO TTM revenue has changed by +$7.22 M (+4.70%)